All Stories

  1. Plant Dehydrin-Derived, Lysine-Rich Peptides Show Both Antifungal Activity and Blood–Brain Barrier Penetration
  2. Synthetic Cyclic C5-Curcuminoids Mitigate Oxidative, Apoptotic and Inflammatory Damage in a 6-OHDA-Induced Neuron–Microglia Co-Culture Model of Neuronal Damage
  3. Clazosentan Attenuates Endothelin-1-Induced ETA Protein Upregulation and Contractile Sensitization in Brain Pericytes
  4. N , N -dimethyltryptamine mitigates experimental stroke by stabilizing the blood-brain barrier and reducing neuroinflammation
  5. Much More than Nutrients: The Protective Effects of Nutraceuticals on the Blood–Brain Barrier in Diseases
  6. Evaluation of Permeability, Safety, and Stability of Nanosized Ketoprofen Co-Spray-Dried with Mannitol for Carrier-Free Pulmonary Systems
  7. Synergistic induction of blood–brain barrier properties
  8. 17-Oxime ethers of oxidized ecdysteroid derivatives modulate oxidative stress in human brain endothelial cells and dose-dependently might protect or damage the blood-brain barrier
  9. Lab-on-a-chip models of the blood–brain barrier: evolution, problems, perspectives
  10. Design, Optimization, and Application of a 3D-Printed Polymer Sample Introduction System for the ICP-MS Analysis of Nanoparticles and Cells
  11. Correction to “Highly Oxidized Ecdysteroids from a Commercial Cyanotis arachnoidea Root Extract as Potent Blood–Brain Barrier Protective Agents”
  12. 17-Oxime ethers of oxidized ecdysteroid derivatives modulate oxidative stress in human brain endothelial cells and dose-dependently might protect or damage the blood-brain barrier
  13. The Use of Sensors in Blood-Brain Barrier-on-a-Chip Devices: Current Practice and Future Directions
  14. Highly Oxidized Ecdysteroids from a Commercial Cyanotis arachnoidea Root Extract as Potent Blood–Brain Barrier Protective Agents
  15. Targeting Human Endothelial Cells with Glutathione and Alanine Increases the Crossing of a Polypeptide Nanocarrier through a Blood–Brain Barrier Model and Entry to Human Brain Organoids
  16. Effects of sub-chronic, in vivo administration of sigma-1 receptor ligands on platelet and aortic arachidonate cascade in streptozotocin-induced diabetic rats
  17. Effects of Hydroxypropyl-Beta-Cyclodextrin on Cultured Brain Endothelial Cells
  18. Cellular Therapy Using Epitope-Imprinted Composite Nanoparticles to Remove α-Synuclein from an In Vitro Model
  19. Distinct Uptake Routes Participate in Silver Nanoparticle Engulfment by Earthworm and Human Immune Cells
  20. Immunofluorescent Evidence for Nuclear Localization of Aromatase in Astrocytes in the Rat Central Nervous System
  21. Effects of sub-chronic, in vivo administration of sigma-1 receptor ligands on platelet and aortic arachidonate cascade in streptozotocin-induced diabetic rats
  22. The Active Role of Pericytes During Neuroinflammation in the Adult Brain
  23. Penetration of the SARS-CoV-2 Spike Protein across the Blood–Brain Barrier, as Revealed by a Combination of a Human Cell Culture Model System and Optical Biosensing
  24. A Triple Combination of Targeting Ligands Increases the Penetration of Nanoparticles across a Blood-Brain Barrier Culture Model
  25. In Vitro Comparative Study of Solid Lipid and PLGA Nanoparticles Designed to Facilitate Nose-to-Brain Delivery of Insulin
  26. Inhibition of NHE-1 Increases Smoke-Induced Proliferative Activity of Barrett’s Esophageal Cell Line
  27. Characterization of a Primate Blood-Brain Barrier Co-Culture Model Prepared from Primary Brain Endothelial Cells, Pericytes and Astrocytes
  28. Identification of Reference Genes for Circadian Studies on Brain Microvessels and Choroid Plexus Samples Isolated from Rats
  29. MAP Kinase Pathways in Brain Endothelial Cells and Crosstalk with Pericytes and Astrocytes Mediate Contrast-Induced Blood–Brain Barrier Disruption
  30. Optically Manipulated Microtools to Measure Adhesion of the Nanoparticle-Targeting Ligand Glutathione to Brain Endothelial Cells
  31. Pitavastatin Ameliorates Lipopolysaccharide-Induced Blood-Brain Barrier Dysfunction
  32. Effect of Lipopolysaccharide-Induced Inflammatory Challenge on β-Glucuronidase Activity and the Concentration of Quercetin and Its Metabolites in the Choroid Plexus, Blood Plasma and Cerebrospinal Fluid
  33. Transendothelial Electrical Resistance Measurement across the Blood–Brain Barrier: A Critical Review of Methods
  34. Bicarbonate Evokes Reciprocal Changes in Intracellular Cyclic di-GMP and Cyclic AMP Levels in Pseudomonas aeruginosa
  35. Surface charge, glycocalyx, and blood-brain barrier function
  36. Development of In Situ Gelling Meloxicam-Human Serum Albumin Nanoparticle Formulation for Nose-to-Brain Application
  37. New Approach in Ocular Drug Delivery: In vitro and ex vivo Investigation of Cyclodextrin-Containing, Mucoadhesive Eye Drop Formulations
  38. ApoE-Targeting Increases the Transfer of Solid Lipid Nanoparticles with Donepezil Cargo across a Culture Model of the Blood–Brain Barrier
  39. Development and Characterization of Potential Ocular Mucoadhesive Nano Lipid Carriers Using Full Factorial Design
  40. The Effect of Sodium Bicarbonate, a Beneficial Adjuvant Molecule in Cystic Fibrosis, on Bronchial Epithelial Cells Expressing a Wild-Type or Mutant CFTR Channel
  41. Simvastatin, edaravone and dexamethasone protect against kainate-induced brain endothelial cell damage
  42. A chip device to determine surface charge properties of confluent cell monolayers by measuring streaming potential
  43. Species-specific sensitivity of Eisenia earthworms towards noble metal nanoparticles: a multiparametric in vitro study
  44. Encapsulation in Polymeric Nanoparticles Enhances the Enzymatic Stability and the Permeability of the GLP-1 Analog, Liraglutide, Across a Culture Model of Intestinal Permeability
  45. Lidocaine turns the surface charge of biological membranes more positive and changes the permeability of blood-brain barrier culture models
  46. Preparation of bivalent agonists for targeting the mu opioid and cannabinoid receptors
  47. Pericytes Suppress Brain Metastasis from Lung Cancer In Vitro
  48. MASP-1 Increases Endothelial Permeability
  49. Dual Action of the PN159/KLAL/MAP Peptide: Increase of Drug Penetration across Caco-2 Intestinal Barrier Model by Modulation of Tight Junctions and Plasma Membrane Permeability
  50. Cerebrovascular Pathology in Hypertriglyceridemic APOB-100 Transgenic Mice
  51. Structural Optimization of Foldamer-Dendrimer Conjugates as Multivalent Agents against the Toxic Effects of Amyloid Beta Oligomers
  52. Niosomes decorated with dual ligands targeting brain endothelial transporters increase cargo penetration across the blood-brain barrier
  53. Antibiotic-resistant bacteria show widespread collateral sensitivity to antimicrobial peptides
  54. Comparison of a Rat Primary Cell-Based Blood-Brain Barrier Model With Epithelial and Brain Endothelial Cell Lines: Gene Expression and Drug Transport
  55. Protection of cultured brain endothelial cells from cytokine-induced damage by α-melanocyte stimulating hormone
  56. Optimization of a combined wet milling process in order to produce poly(vinyl alcohol) stabilized nanosuspension
  57. Biotin and Glutathione Targeting of Solid Nanoparticles to Cross Human Brain Endothelial Cells
  58. From the Cover: In Vitro and In Vivo Blood-Brain Barrier Penetration Studies with the Novel Cyanide Antidote Candidate Dimethyl Trisulfide in Mice
  59. Claudin peptidomimetics modulate tissue barriers for enhanced drug delivery
  60. The small molecule AUTEN-99 (autophagy enhancer-99) prevents the progression of neurodegenerative symptoms
  61. Alpha-Melanocyte Stimulating Hormone Protects against Cytokine-Induced Barrier Damage in Caco-2 Intestinal Epithelial Monolayers
  62. Validation of UHPLC–MS/MS methods for the determination of kaempferol and its metabolite 4-hydroxyphenyl acetic acid, and application to in vitro blood-brain barrier and intestinal drug permeability studies
  63. Intraperitoneally administered IgG from patients with amyotrophic lateral sclerosis or from an immune-mediated goat model increase the levels of TNF-α, IL-6, and IL-10 in the spinal cord and serum of mice
  64. Cytotoxicity of Different Excipients on RPMI 2650 Human Nasal Epithelial Cells
  65. Pharmacokinetics and In Vitro Blood-Brain Barrier Screening of the Plant-Derived Alkaloid Tryptanthrin
  66. In vitro models of the blood–brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use
  67. Reversible Opening of Intercellular Junctions of Intestinal Epithelial and Brain Endothelial Cells With Tight Junction Modulator Peptides
  68. Restraint Stress-Induced Morphological Changes at the Blood-Brain Barrier in Adult Rats
  69. Anion-/cation-directed reaction routes to polymorphic forms of a pyrazole-type ligand and its coordination compounds with zinc. Key structural differences between polymorphs’
  70. A versatile lab-on-a-chip tool for modeling biological barriers
  71. Evaluation of the Cytotoxicity of α-Cyclodextrin Derivatives on the Caco-2 Cell Line and Human Erythrocytes
  72. Opposite effect of Ca2+/Mg2+ ions on the aggregation of native and precursor-derived Aβ42
  73. Transfer of Opiorphin Through a Blood-Brain Barrier Culture Model
  74. Supermacroporous chemically cross-linked poly(aspartic acid) hydrogels
  75. Molecule helps to open the barrier protecting brain tumors
  76. Cultured cells of the blood–brain barrier from apolipoprotein B-100 transgenic mice: effects of oxidized low-density lipoprotein treatment
  77. In VitroAssays for Assessing BBB Permeability
  78. The Absence of N-Acetyl-D-glucosamine Causes Attenuation of Virulence ofCandida albicansupon Interaction with Vaginal Epithelial CellsIn Vitro
  79. Preparation and investigation of mefenamic acid – polyethylene glycol – sucrose ester solid dispersions
  80. Candesartan Improves Ischemia-Induced Impairment of the Blood–Brain Barrier In Vitro
  81. Low Dose Cranial Irradiation-Induced Cerebrovascular Damage Is Reversible in Mice
  82. Role of the Blood–Brain Barrier in the Nutrition of the Central Nervous System
  83. Preface
  84. Cyclodextrins, Blood–Brain Barrier, and Treatment of Neurological Diseases
  85. Compounds Blocking Methylglyoxal-induced Protein Modification and Brain Endothelial Injury
  86. Sucrose Esters Increase Drug Penetration, But Do Not Inhibit P‐Glycoprotein in Caco‐2 Intestinal Epithelial Cells
  87. Development and validation of a LC–MS/MS method for assessment of an anti-inflammatory indolinone derivative by in vitro blood–brain barrier models
  88. Edaravone Protects against Methylglyoxal-Induced Barrier Damage in Human Brain Endothelial Cells
  89. Cilostazol attenuates ischemia–reperfusion-induced blood–brain barrier dysfunction enhanced by advanced glycation endproducts via transforming growth factor-β1 signaling
  90. Hepatocyte growth factor enhances the barrier function in primary cultures of rat brain microvascular endothelial cells
  91. Efflux transport of serum amyloid P component at the blood-brain barrier
  92. In vitro and in vivo characterization of meloxicam nanoparticles designed for nasal administration
  93. pH- and temperature-responsive poly(aspartic acid)-l-poly(N-isopropylacrylamide) conetwork hydrogel
  94. Effects of polymers on the crystallinity of nanonized meloxicam during a co-grinding process
  95. Acute effects of short-chain alkylglycerols on blood-brain barrier properties of cultured brain endothelial cells
  96. Docosahexaenoic Acid Reduces Amyloid-β Induced Toxicity in Cells of the Neurovascular Unit
  97. Kinetic Analysis of the Toxicity of Pharmaceutical Excipients Cremophor EL and RH40 on Endothelial and Epithelial Cells
  98. Cilostazol Strengthens Barrier Integrity in Brain Endothelial Cells
  99. Evaluation of cytotoxicity of surfactants used in self-micro emulsifying drug delivery systems and their effects on paracellular transport in Caco-2 cell monolayer
  100. Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood–brain barrier penetration models
  101. Retinoic acid and hydrocortisone strengthen the barrier function of human RPMI 2650 cells, a model for nasal epithelial permeability
  102. Exposure to Lipopolysaccharide and/or Unconjugated Bilirubin Impair the Integrity and Function of Brain Microvascular Endothelial Cells
  103. The effect of sucrose esters on a culture model of the nasal barrier
  104. Tools for Modelling Blood-Brain Barrier Penetrability
  105. Drug Transport and the Blood-Brain Barrier
  106. Organometallic polymeric carriers for redox triggered release of molecular payloads
  107. Randomly methylated β‐cyclodextrin derivatives enhance taxol permeability through human intestinal epithelial Caco‐2 cell monolayer
  108. Study of the parameters influencing the co-grinding process for the production of meloxicam nanoparticles
  109. Oxygen–glucose deprivation increases the enzymatic activity and the microvesicle-mediated release of ectonucleotidases in the cells composing the blood–brain barrier
  110. Applicability of sucrose laurate as surfactant in solid dispersions prepared by melt technology
  111. Patented In Vitro Blood-Brain Barrier Models in CNS Drug Discovery
  112. Glial Cells Drive Preconditioning-Induced Blood-Brain Barrier Protection
  113. Intracellular transport of Toxoplasma gondii through the blood–brain barrier
  114. Protection of the Blood-Brain Barrier by Pentosan Against Amyloid-β-Induced Toxicity
  115. Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters
  116. Effect of Nanogold Particles on Coupled Plasmon Resonance on Biomolecule Covered Prepatterned Multilayers
  117. Pitavastatin Strengthens the Barrier Integrity in Primary Cultures of Rat Brain Endothelial Cells
  118. Human Truncated Tau is Using a Different Mechanism from Amyloid-β to Damage the Blood-Brain Barrier
  119. Intranasal Delivery of Human β-Amyloid Peptide in Rats: Effective Brain Targeting
  120. Sodium hyaluronate as a mucoadhesive component in nasal formulation enhances delivery of molecules to brain tissue
  121. Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery
  122. A new blood–brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes
  123. Epithelial and endothelial barriers in the olfactory region of the nasal cavity of the rat
  124. Effect of nicotine and polyaromtic hydrocarbons on cerebral endothelial cells
  125. Comparative study of sub-micrometer polymeric structures: Dot-arrays, linear and crossed gratings generated by UV laser based two-beam interference, as surfaces for SPR and AFM based bio-sensing
  126. Bio-sensing based on plasmon-coupling caused by rotated sub-micrometer gratings in metal-dielectric interfacial layers
  127. Pericytes from Brain Microvessels Strengthen the Barrier Integrity in Primary Cultures of Rat Brain Endothelial Cells
  128. Highly activated c-fos expression in specific brain regions (ependyma, circumventricular organs, choroid plexus) of histidine decarboxylase deficient mice in response to formalin-induced acute pain
  129. Atomic force microscopical and surface plasmon resonance spectroscopical investigation of sub-micrometer metal gratings generated by UV laser-based two-beam interference in Au–Ag bimetallic layers
  130. A functional in vitro model of rat blood–brain barrier for molecular analysis of efflux transporters
  131. The NMDA and AMPA/KA Receptors are Involved in Glutamate-Induced Alterations of Occludin Expression and Phosphorylation in Brain Endothelial Cells
  132. Pentosan polysulfate protects brain endothelial cells against bacterial lipopolysaccharide-induced damages
  133. Blood–Brain Barrier Models
  134. Induction of aquaporin 1 by dexamethasone in lipid rafts in immortalized brain microvascular endothelial cells
  135. Sub-micrometer adhesion modulation on polymer surfaces containing gratings produced by two-beam interference
  136. Signaling Mechanisms of HIV-1 Tat-Induced Alterations of Claudin-5 Expression in Brain Endothelial Cells
  137. Puromycin-based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood-brain barrier-specific properties
  138. Permeability Studies on In Vitro Blood–Brain Barrier Models: Physiology, Pathology, and Pharmacology
  139. Human serum amyloid P component attenuates the bacterial lipopolysaccharide-induced increase in blood–brain barrier permeability in mice
  140. HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells
  141. Vascular changes play a role in the pathogenesis of necrotizing enterocolitis in asphyxiated newborn pigs
  142. N , N -diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine increases the permeability of primary mouse cerebral endothelial cell monolayers
  143. Adrenomedullin, an Autocrine Mediator of Blood-Brain Barrier Function
  144. Expression of Protein Kinase C Family Members in the Cerebral Endothelial Cells
  145. Adrenomedullin and Migraine
  146. Cerebral Endothelial Cells are a Major Source of Adrenomedullin
  147. Adrenomedullin regulates blood???brain barrier functions in vitro
  148. Enhancing effect of zinc on astroglial and cerebral endothelial histamine uptake11Abbreviations: HA, histamine; FCS, fetal calf serum; MEM, minimal essential medium; and NEM, N-ethylmaleimide.
  149. Adrenomedullin in the cerebral circulation
  150. Asphyxia-induced release of α-melanocyte-stimulating hormone in newborn pigs
  151. Tissue plasminogen activator inhibits P-glycoprotein activity in brain endothelial cells
  152. Effects of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine on the blood–brain barrier permeability in the rat
  153. Regional differences in asphyxia- and reperfusion-induced cytotoxic and vasogenic brain edema formation in newborn pigs
  154. Mannose-binding lectin and meningococcal disease
  155. Mannose-binding lectin and meningococcal disease
  156. 4-(2-Aminoethyl)benzenesulfonyl fluoride attenuates tumor-necrosis-factor-α-induced blood–brain barrier opening
  157. Cerebral microvascular acid phosphatase isoenzymes may contribute to the histamine-induced changes in the blood-brain barrier permeability
  158. Pentosan in transmissible spongiform encephalopathies
  159. Vasoactive substances produced by cultured rat brain endothelial cells
  160. Expression of glutamate receptors on cultured cerebral endothelial cells
  161. Expression of glutamate receptors on cultured cerebral endothelial cells
  162. Expression of G-protein subtypes in cultured cerebral endothelial cells
  163. Experimental acute pancreatitis results in increased blood–brain barrier permeability in the rat: a potential role for tumor necrosis factor and interleukin 6
  164. Mercury‐stimulated histamine uptake and binding in cultured astroglial and cerebral endothelial cells
  165. Mercury-stimulated histamine uptake and binding in cultured astroglial and cerebral endothelial cells
  166. THE INFLUENCE OF OXYGEN FREE RADICALS ON THE PERMEABILITY OF THE MONOLAYER OF CULTURED BRAIN ENDOTHELIAL CELLS
  167. Intracarotid tumor necrosis factor-α administration increases the blood-brain barrier permeability in cerebral cortex of the newborn pig: quantitative aspects of double-labelling studies and confocal laser scanning analysis
  168. Cultured Vascular Endothelial Cells of the Brain.
  169. Exposure of tumor necrosis factor-α to luminal membrane of bovine brain capillary endothelial cells cocultured with astrocytes induces a delayed increase of permeability and cytoplasmic stress fiber formation of actin
  170. Penetration of small molecular weight substances through cultured bovine brain capillary endothelial cell monolayers: the early effects of cyclic adenosine 3',5'-monophosphate
  171. Histamine induces a selective albumin permeation through the blood-brain barrierin vitro
  172. Carrier-mediated uptake and release of histamine by cultured rat cerebral endothelial cells
  173. Calcium/Calmodulin‐Stimulated Protein Kinase II Is Present in Primary Cultures of Cerebral Endothelial Cells